COVID-19

3D rendering of SARS-CoV-2 virus particles
Biotech

Dynavax pays Vaxart $30M for oral COVID-19 vaccine program

The deal allows Dynavax to see phase 2b data before placing a bigger bet on the program.
Nick Paul Taylor Nov 6, 2025 5:50am
cartoon of man unplugging from outlet

Pfizer pulls the plug on 11 programs

Nov 4, 2025 2:40pm
Sketch of lungs

Edesa claims survival win for phase 3 respiratory failure trial

Oct 28, 2025 9:45am
Abbott

Abbott device growth offsets diagnostics sales slide in Q3

Oct 15, 2025 11:00am
generic visual of COVID-19 vaccine booster shot
Favicon Fierce Pharma

ACIP narrowly votes against COVID vaccine prescriptions

Sep 19, 2025 5:22pm
Robert F Kennedy Jr conducts a news conference to discuss the Centers for Disease Control and Preventions latest Autism a
Favicon Fierce Pharma

RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation

Sep 4, 2025 3:51pm
More News

NIH head says public distrust prompted mRNA vaccine rollback

Aug 12, 2025 2:08pm

Vaxart seeks answers as BARDA vaccine funding dries up again

Aug 12, 2025 5:08am

Imunon puts COVID vaccine on ice, seeks partner amid cash crunch

Aug 5, 2025 9:55am

UK puts down $335M for new pandemic preparedness research center

Jul 17, 2025 1:09pm